Close

Baxter (BAX) Expands Pharmaceuticals Portfolio with New Injectable Products in the U.S. Apr 11, 2024 08:32AM
Baxter Expands Pharmaceuticals Portfolio with New Injectable Products in the U.S. Apr 11, 2024 08:30AM
Baxter to Host First-Quarter 2024 Financial Results Conference Call for Investors Apr 10, 2024 04:15PM
Baxter (BAX) Announces FDA Clearance of Novum IQ Large Volume Infusion Pump and Dose IQ Safety Software Apr 1, 2024 07:16AM
Baxter Announces U.S. FDA Clearance of Novum IQ Large Volume Infusion Pump and Dose IQ Safety Software, Advancing Connected and Intelligent Infusion Therapy Apr 1, 2024 07:15AM
View Older Stories

Mar 27, 2024 09:00AM Baxter to Host Annual Meeting of Stockholders in Virtual Format
Feb 29, 2024 04:15PM Baxter to Present at Raymond James 45th Annual Institutional Investors Conference
Feb 12, 2024 06:15PM Baxter Declares Quarterly Dividend
Feb 8, 2024 07:15AM Baxter Reports Fourth-Quarter and Full-Year 2023 Results
Jan 4, 2024 04:15PM Baxter to Host Fourth-Quarter 2023 Financial Results Conference Call for Investors
Jan 4, 2024 03:05PM Nuwellis (NUWE) Receives FDA Clearance for an Additional Dual Lumen Extended Length Peripheral Catheter
Jan 4, 2024 03:05PM Nuwellis Receives FDA Clearance for an Additional Dual Lumen Extended Length Peripheral Catheter
Dec 14, 2023 08:00AM Baxter Advances First Intravenous (IV) Bag Recycling Pilot for U.S. Hospitals
Dec 13, 2023 04:30PM Baxter to Present at 42nd Annual J.P. Morgan Healthcare Conference
Dec 11, 2023 09:00AM Baxter Publishes Task Force on Climate-Related Financial Disclosures (TCFD) Report and Is Named to Dow Jones Sustainability Index North America
Nov 28, 2023 08:09AM Nuwellis (NUWE) Announces New Real-World Data Highlight the Clinical Benefits of Ultrafiltration Therapy with Hematocrit Monitoring for Pediatric Patients
Nov 28, 2023 08:00AM New Real-World Data Highlight the Clinical Benefits of Ultrafiltration Therapy with Hematocrit Monitoring for Pediatric Patients
Nov 14, 2023 04:30PM Baxter Declares Quarterly Dividend
Nov 14, 2023 04:30PM Nuwellis, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Nov 6, 2023 08:30AM Baxter Highlights New Data at Kidney Week Indicating Sharesource Is Associated With a 77% Lower Risk of Home Dialysis Technique Failure
Nov 2, 2023 07:15AM Baxter Reports Third-Quarter 2023 Results
Nov 1, 2023 08:00AM Nuwellis Announces Board of Directors Transition
Oct 31, 2023 08:00AM Nuwellis’ Strategic Partner, SeaStar Medical, Receives FDA Approvable Letter for Its Pediatric Selective Cytopheretic Device
Oct 16, 2023 09:00AM Baxter Launches Digital Image Capture Capability for PanOptic Plus Ophthalmoscope
Oct 3, 2023 09:01AM Baxter (BAX) Appoints Joel Grade Chief Financial Officer
Oct 3, 2023 09:00AM Baxter Appoints Joel Grade Chief Financial Officer
Sep 19, 2023 04:15PM Baxter to Host Third-Quarter 2023 Financial Results Conference Call for Investors
Sep 3, 2023 11:31AM ROSEN, A LEADING LAW FIRM, Encourages Baxter International Inc. Investors With Losses to Secure Counsel Before Important September 11 Deadline in Securities Class Action – BAX
Aug 29, 2023 04:15PM Baxter to Present at Morgan Stanley 21st Annual Global Healthcare Conference
Aug 28, 2023 08:27PM ROSEN, SKILLED INVESTOR COUNSEL, Encourages Baxter International Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – BAX
Aug 24, 2023 08:30AM Advent International and Warburg Pincus Name Franco Negron CEO of BioPharma Solutions Following its Proposed Divestiture from Baxter
Aug 22, 2023 04:15PM Baxter to Present at 2023 Wells Fargo Healthcare Conference
Aug 21, 2023 05:00PM Baxter (BAX) Announces Board Changes
Aug 21, 2023 05:00PM Baxter Announces Updates to Its Board of Directors
Aug 13, 2023 08:52AM ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Baxter International Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – BAX
Jul 27, 2023 07:30AM Baxter Reports Second-Quarter 2023 Results
Jul 25, 2023 08:16AM Baxter (BAX) Picks Vantive as the Name of Proposed Kidney Care Spinoff
Jul 25, 2023 08:15AM Baxter Announces Vantive as the Name of Proposed Kidney Care Spinoff
Jul 24, 2023 08:00AM Baxter Launches PERCLOT Absorbable Hemostatic Powder
Jul 18, 2023 04:15PM Baxter Declares Quarterly Dividend
Jul 17, 2023 08:00PM ROSEN, SKILLED INVESTOR COUNSEL, Encourages Baxter International Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – BAX
Jun 29, 2023 04:16PM Baxter (BAX) Appoints William Ampofo to Its Board
Jun 29, 2023 04:15PM Baxter Appoints William Ampofo to Its Board
Jun 29, 2023 09:00AM Baxter Launches Progressa+ Next Gen ICU Bed to Help Address Complex Critical Care Needs
Jun 26, 2023 08:30AM Baxter Publishes Annual Corporate Responsibility Report, Reinforcing Longstanding Commitment to Making a Meaningful Difference
Jun 20, 2023 08:30AM Nuwellis Inc. Announces Pilot Agreement With DaVita Inc.
Jun 13, 2023 04:30PM Baxter to Host Second-Quarter 2023 Financial Results Conference Call for Investors
Jun 13, 2023 04:15PM Nuwellis to Participate in the Maxim Group Virtual Healthcare Conference
Jun 5, 2023 04:17PM Nuwellis (NUWE) Announces Appointment of Mike McCormick to its Board of Directors
Jun 5, 2023 04:15PM Nuwellis Announces the Appointment of Mike McCormick to its Board of Directors
May 24, 2023 04:15PM Baxter to Present at Jefferies Healthcare Conference
May 23, 2023 08:04AM Artivion (AORT) Announces FDA PMA Approval of PerClot and Transfer of PMA to Baxter (BAX)
May 23, 2023 08:04AM Artivion Announces FDA PMA Approval of PerClot and Transfer of PMA to Baxter
May 22, 2023 05:10PM Nuwellis, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 9, 2023 08:16AM Baxter (BAX) Announces CFO Transition, Maintains Outlook
View Older Stories